Skip Navigation Links.
Collapse <span class="m110 colortj mt20 fontw700">Volume 12 (2024)</span>Volume 12 (2024)
Collapse <span class="m110 colortj mt20 fontw700">Volume 11 (2023)</span>Volume 11 (2023)
Collapse <span class="m110 colortj mt20 fontw700">Volume 10 (2022)</span>Volume 10 (2022)
Collapse <span class="m110 colortj mt20 fontw700">Volume 9 (2021)</span>Volume 9 (2021)
Collapse <span class="m110 colortj mt20 fontw700">Volume 8 (2020)</span>Volume 8 (2020)
Collapse <span class="m110 colortj mt20 fontw700">Volume 7 (2019)</span>Volume 7 (2019)
Collapse <span class="m110 colortj mt20 fontw700">Volume 6 (2018)</span>Volume 6 (2018)
Collapse <span class="m110 colortj mt20 fontw700">Volume 5 (2017)</span>Volume 5 (2017)
Collapse <span class="m110 colortj mt20 fontw700">Volume 4 (2016)</span>Volume 4 (2016)
Collapse <span class="m110 colortj mt20 fontw700">Volume 3 (2015)</span>Volume 3 (2015)
Collapse <span class="m110 colortj mt20 fontw700">Volume 2 (2014)</span>Volume 2 (2014)
Collapse <span class="m110 colortj mt20 fontw700">Volume 1 (2013)</span>Volume 1 (2013)
American Journal of Medical Case Reports. 2020, 8(9), 311-312
DOI: 10.12691/AJMCR-8-9-13
Original Research

COVID-19 Pandemic and the New State of Oncology Practice: An Editorial

Hani Ashamalla1, Mark Ashamalla1 and Samy I. McFarlane2,

1Radiation Oncology Department, New York Presbyterian- Brooklyn Methodist hospital, Brooklyn, NY USA

2Department of Medicine, Downstate -Health Science University, Brooklyn, NY USA

Pub. Date: June 08, 2020
Full Text PDF

Cite this paper

Hani Ashamalla, Mark Ashamalla and Samy I. McFarlane. COVID-19 Pandemic and the New State of Oncology Practice: An Editorial. American Journal of Medical Case Reports. 2020; 8(9):311-312. doi: 10.12691/AJMCR-8-9-13

Abstract

Keywords

COVID-19, SARS-Cov-2, oncology practice, cancer

Copyright

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]  Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020; 21(3): 335‐337.
 
[2]  J. Ferlay, M. Ervik, F. Lam, et al. Global Cancer Observatory: Cancer Today International Agency for Research on Cancer, Lyon, France (2018). https://gco.iarc.fr/today, Accessed 5th Apr 2020
 
[3]  Yang F, Shi S, Zhu J, Shi J, Dai K, Chen X. Clinical characteristics and outcomes of cancer patients with COVID-19 [published online ahead of print, 2020 May 5]. J Med Virol. 2020; 10.1002/jmv.25972.
 
[4]  Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science 2011; 331: 1565-70.
 
[5]  Cai G. Bulk and single-cell transcriptomics identify tobacco-use disparity in lung gene expression of ACE2, the receptor of 2019-nCov. medRxiv 2020.
 
[6]  Xia Y, Jin R, Zhao J, Li W, Shen H. Risk of COVID-19 for patients with cancer. Lancet Oncol. 2020; 21(4):e180.
 
[7]  Kattan J, Kattan C, Assi T. Do checkpoint inhibitors compromise the cancer patients' immunity and increase the vulnerability to COVID-19 infection?. Immunotherapy. 2020; 12(6): 351-354.
 
[8]  Nagar, H., Formenti, S.C. Cancer and COVID-19 — potentially deleterious effects of delaying radiotherapy. Nat Rev Clin Oncol (2020).
 
[9]  Kutikov A, Weinberg DS, Edelman MJ, Horwitz EM, Uzzo RG, Fisher RI. A War on Two Fronts: Cancer Care in the Time of COVID-19 [published online ahead of print, 2020 Mar 27]. Ann Intern Med. 2020; M20-1133.
 
[10]  Shimabukuro-Vornhagen A, Gödel P, Subklewe M, et al. Cytokine release syndrome. J Immunother Cancer. 2018; 6(1): 56. Published 2018 Jun 15.